Notice ID: c44524dd912c4963a119b8ceb37548efCombined Synopsis/Solicitation
Portfolio Impact Analysis for the Therapeutic Development Branch (TDB), NCATS
Archived on September 30, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:00 PM UTC−04:00
- Posted
- September 11, 2024
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- SBA Certified Women-Owned Small Business (WOSB) Program Set-Aside (FAR 19.15)
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95024Q00564
- Notice ID
- c44524dd912c4963a119b8ceb37548ef
Description
Amendment 1 (9/11/2024): Adding Q&A as an attachment to the solicitation. See attached. The Therapeutic Development Branch (TDB) in the intramural Division of Preclinical Innovation (DPI) at the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) was established to enable preclinical development through collaborative partnerships. In alignment with accomplishing the Centers mission, the Branch needs to conduct a portfolio impact analysis, from its inception in 2010 to present. The goal is to capture key metrics and evaluate the programs research outcomes, including analyzing the economic and other quantitative and qualitative impact measures on further research and development and healthcare. TDB requires the expertise of a firm capable of conducting such types of specialized impact analyses of novel therapeutics and related technologies. The results of this analysis will be used by Branch leadership to inform future research policy and priorities. See the attached Combined Synopsis/Solicitation, Statement of Work, and other attachments for complete requirement details.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95024Q00564- Combined Synopsis
- 2×Combined SynopsisCurrentSep 5, 2024
Portfolio Impact Analysis for the Therapeutic Development Branch (TDB), NCATS
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95024Q00564
Archive Date
Sep 30, 2024
Office Address
Bethesda, MD, 20892